Business Context and Reporting Period
This Form 8-K filing by The Trade Desk, Inc. (TTD) covers events occurring between March 19, 2026, and March 25, 2026. The report details significant changes to the Company's Board of Directors, resulting in a temporary non-compliance with Nasdaq listing rules regarding committee composition.
Key Financial Metrics
The filing does not provide operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to director compensation and a specific separation payment:
- Director Compensation (Andrew Vollero): Annual cash compensation of $50,000 for Board service and $12,500 for Audit Committee service.
- Director Equity Grants (Andrew Vollero): Initial grant valued at $290,000 and an annual grant valued at $290,000 (prorated).
- Separation Payment (Alexander Kayyal): A $400,000 relocation amount paid in connection with his prior departure as Chief Financial Officer.
Material Changes Versus Prior Period
The primary material change is the reduction in Board membership and committee staffing:
- Resignations: Alexander Kayyal resigned from the Board effective March 19, 2026. Kathryn E. Falberg resigned effective March 23, 2026. Both resignations were not due to disagreements with the Company.
- Appointment: Andrew Vollero was appointed to the Board and Audit Committee, effective April 3, 2026, to fill a vacancy left by Gokul Rajaram.
- Listing Status: Due to the resignations, the Company fell out of compliance with Nasdaq Listing Rules 5605(c)(2)(A) and 5605(d)(2)(A) regarding the minimum number of independent directors on the Audit and Compensation Committees.
Guidance, Outlook, and Risks
Regulatory Compliance and Cure Period: The Company received a notice of noncompliance from Nasdaq on March 25, 2026. It has been granted a cure period until September 21, 2026, to regain compliance with committee composition rules. Management intends to fill vacancies as expeditiously as possible.
Risks and Contingencies: The filing notes no disagreements regarding the resignations of Messrs. Kayyal and Ms. Falberg. There are no undisclosed arrangements regarding the appointment of Mr. Vollero.
Investor Verification Checklist
- Verify the Company's progress in appointing additional independent directors to the Audit and Compensation Committees before the September 21, 2026, deadline.
- Confirm the final vesting schedule and form (stock vs. options) of the equity grants awarded to Andrew Vollero.
- Monitor for any further announcements regarding the Board composition or potential delisting risks if the cure period expires without compliance.